Host Login

| Eastern Time (US & Canada) (GMT -4:00)

Mon Oct 26 at 10:30 AM EDT | Eastern Time (US & Canada)

|
Webinar will be recorded

AI Case Studies in Discovery & Clinical Development

ABOUT THIS WEBINAR

Biopharmas can use code BIOPHARMA100 to register for free.
----

10:30-11:00am -
Target Identification, Validation & Molecule Generation

Martin Akerman, CTO, Envisagenics
Spyro Mousses, CEO, Systems Oncology

----

11:00 - 11:30am
How to Approach Predictive ADMET Modeling and Maximize its Impact on Drug Discovery Projects
• Retrospective analysis of results in ADMET
• The importance of culture – getting the chemistry teams in the right mindset, using the advanced AI/ML technologies, and willing to incorporate the predictions and move ahead using models – use cases
• ADMET models and technologies are better so what’s the future for solving the potency and selectivity challenges?

Barun Bhhatarai, Investigator, Novartis Institutes for BioMedical Research (NIBR)
Marcel Hop, Vice President, Drug Metabolism and Pharmacokinetics, Genentech

----

11:30 - 11:45
Innovation Spotlight Presentations

Rafael Rosengarten, PhD, CEO, Genialis
• Tackling the "Small Data Problem": Integration and Harmonization Strategies To Unlock the Potential of Clinical Trial Datasets

Ariel Katz, Co-Founder, H1
• Leveraging AI to Aggregate Healthcare Data and HCP Data

----

11:45 - 12:30
Leader Perspectives in Clinical Development: Achieving Consistency in Validating & Operationalizing the AI/ML Automation Efforts Transforming Biopharma

Although certain intelligent automation technologies have been used in some PV areas for years (e.g. rule-based software, auto-coding, auto-narrative generation, etc.), rapid development of newer technologies (e.g. machine learning, natural language processing) has outpaced some PV regulations. Therefore, continued innovation will be more likely and ultimately more successful if companies and 3rd party developers can be reasonably assured they have adequately validated their systems and automated processes.

A panel of biopharma leaders will delve into:
• IAO in the past and now – how it’s transforming our work
• Specific Intelligent Automation Opportunities in Pharmacovigilance Solutions
- Short Term - Validation Proposal
- Long Term - to Transform and Accelerate

Moderator
Neal Grabowski, MEng, MBA, Director, Safety Data Science, AbbVie; Intelligent Automation Opportunities (IAO) in PV Workstream Lead, TransCelerate BioPharma, Inc.

Danielle Abatemarco, MSc, Scientific Publications Lead, WorldWide Patient Safety, Bristol-Myers Squibb; Intelligent Automation Opportunities (IAO) Workstream Member, TransCelerate BioPharma, Inc.
Andrew Bate, PhD, Head of Safety Innovation & Analytics, GSK Pharmacovigilance Steering Committee Member, TransCelerate BioPharma, Inc.

----

12:30 - 1:00pm
Unconventional AI/ML for the Biomedical Sciences

• Understanding driver biology and Identifying causal drug targets that are driving disease ideology
• Going after the means and the capabilities to drive more effective therapeutics with far fewer associated side effects
• Quantum computing approaches to analysis of multi-omic data

Thomas W. Chittenden, PhD, DPhil, PStat, Chief Data Science Officer, Genuity Science

ADDITIONAL INFO

When: Monday, October 26, 2020 · 10:30 a.m. Eastern Time (US & Canada)
Duration: 2 hours 30 minutes
Price: $95.00
Language: English
Who can attend? Anyone with the event link can attend
Dial-in available? (listen only): Not available.

FEATURED PRESENTERS

Harry Glorikian

General Partners, Scientia Ventures

Passionate about business transformations that accelerate growth, efficiency gains, cost reductions, and competitive advantage for market leaders as well as up-and-coming innovators with next-generation ideas.

Harry Glorikian is an influential...

Full Profile

Martin Akerman

Co-Founder & CTO, Envisagenics

Dr. Martin Akerman is the Co-founder and CTO of Envisagenics. He is the inventor of the SpliceCore software platform, born out of his extensive research experience at the intersection of biology and data science and his vision of discovering RNA...

Full Profile

Spyro Mousses

CEO, Systems Oncology

Dr. Mousses is the cofounder and CEO of Systems Oncology LLC. He is widely recognized as a leading scientist in the application of genomics, systems biology, and machine learning to improve and accelerate cancer drug discovery and development. ...

Full Profile

Barun Bhhatarai

Investigator, Novartis Institutes for BioMedical Research (NIBR)

Full Profile

Marcel Hop

Vice President, Genentech, Drug Metabolism and Pharmacokinetics

Full Profile

Rafael Rosengarten, Ph.D

CEO, Genialis

Rafael leads Genialis’ effort to integrate and mine vast and diverse sources of biomedical knowledge to realize the promise of precision medicine and therapeutic discovery. He spent nearly 20 years in biomedical research prior to Genialis,...

Full Profile

Ariel Katz

Co-Founder, H1

Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Bill and Melinda Gates Foundation and the Ewing...

Full Profile

Thomas W. Chittenden, PhD, DPhil, PStat

Chief Data Science Officer, Genuity Science

Dr. Thomas Chittenden is Chief Data Science Officer and Founding Director of the Genuity Science Advanced Artificial Intelligence Research Laboratory. Dr. Chittenden is responsible for development and execution of our global AI/ML R&D strategy....

Full Profile

Andrew Bate,PhD

Head of Safety Innovation & Analytics, GSK

Full Profile

Neal Grabowski, MEng, MBA

Director, Safety Data Science, AbbVie; Intelligent Automation Opportunities (IAO) in PV Workstream Lead, TransCelerate BioPharma, Inc.

Full Profile

Danielle Abatemarco, MSc

Scientific Publications Lead, WorldWide Patient Safety, Bristol-Myers Squibb; Intelligent Automation Opportunities (IAO) Workstream Member, TransCelerate BioPharma, Inc.

Full Profile

H1

Sponsor

H1 is a data platform for the global healthcare community to track, analyze, and glean insights into the people, organizations, and findings happening every day. With the world’s largest database of over 8million HCPs and Social Media coverage,...

Full Profile

Genialis

Sponsor

Genialis is a computational precision medicine company focused on new ways to treat disease. Blending bioinformatics and machine learning, Genialis models data across translational research and clinical development. Genialis is trusted by...

Full Profile

Genuity Science

Sponsor

Genuity Science is a contract genomics and data-sourcing, -analytics and -insights organization headquartered in Boston, MA, USA with offices in Ireland and Iceland. Genuity partners with global biopharma companies to offer deep end-to-end...

Full Profile

HOSTED BY

AI in Biopharma
We connect the industry’s science minds, AI technology experts, technologists, and strategy leaders through in-person and virtual events and digital content. Our large community of industry leaders are passionate about the work they do and are dedicated to working at the intersection of science and technology. We collaborate with our industry experts to convene engaged discussions and facilitate the translation of AI/ML technologies into patient impact.

Subscribe Contact

ATTENDED (10)